Chromadex (CDXC)
NASDAQ:CDXC
Holding CDXC?
Track your performance easily

Chromadex (CDXC) Income Statement

448 Followers

Chromadex Income Statement

Last quarter (Q2 2024), Chromadex's total revenue was $22.74M, an increase of 8.30% from the same quarter last year. In Q2, Chromadex's net income was $-15.00K. See Chromadex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 85.11M$ 83.57M$ 72.05M$ 67.45M$ 59.26M$ 46.29M
Cost of Revenue
$ 33.58M$ 32.79M$ 29.25M$ -25.96M$ 23.98M$ 20.52M
Gross Profit
$ 51.54M$ 50.78M$ 42.80M$ 41.49M$ 35.27M$ 25.77M
Operating Expense
$ 57.22M$ 56.38M$ 61.42M$ -68.56M$ 55.13M$ 57.07M
Operating Income
$ -5.69M$ -5.60M$ -18.63M$ -27.07M$ -19.85M$ -31.30M
Net Non Operating Interest Income Expense
$ 620.00K$ 661.00K$ 3.00K$ -55.00K$ -71.00K$ -847.00K
Other Income Expense
-$ -649.00K$ -2.08M---
Pretax Income
$ 2.90M$ -4.94M$ -16.54M$ -27.13M$ -19.93M$ -32.15M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -5.07M$ -4.94M$ -1.42M$ -27.13M$ -19.93M$ -32.15M
Basic EPS
$ -0.07$ -0.07$ -0.24$ -0.40$ -0.33$ -0.56
Diluted EPS
$ -0.07$ -0.07$ -0.24$ -0.40$ -0.33$ -0.56
Basic Average Shares
$ 300.37M$ 74.98M$ 69.73M$ 67.19M$ 61.07M$ 57.06M
Diluted Average Shares
$ 300.37M$ 74.98M$ 69.73M$ 67.19M$ 61.07M$ 57.06M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 90.80M$ 89.17M$ 90.68M$ -94.52M$ 79.11M$ 77.59M
Interest Expense
----$ 71.00K$ 847.00K
Net Income From Continuing And Discontinued Operation
$ -5.07M$ -4.94M$ -1.42M$ -27.13M$ -19.93M$ -32.15M
Normalized Income
$ 4.55M---$ -19.93M$ -32.15M
EBIT
$ -5.38M$ -5.60M$ -16.54M$ -27.07M$ -19.85M$ -31.30M
EBITDA
$ -3.68M$ -3.89M$ -14.66M$ -25.45M$ -18.34M$ -29.78M
Currency in USD

Chromadex Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis